** Shares of genetic testing firm 23andMe ME.O fall 42.5% to $1.03 premarket
** On Sunday, ME filed for Chapter 11 bankruptcy protection to facilitate the sale of co
** Co's CEO, Anne Wojcicki, has resigned after her attempts to buy out the company were rejected multiple times
** Wojcicki plans to make another bid to buy the co during the bankruptcy process
** Co has secured $35 mln in financing to continue operating during the sale process
** Co's latest valuation is $50 mln, which is much lower than its $3.5 bln market value when it went public in 2021
** Stock fell 79.5% in the last 12 months
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。